-
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?
Oort, Q., Dirven, L., Sikkes, S. A. M., Aaronson, N., Boele, F., Brannan, C., Egeter, J., Grant, R., Klein, M., Lips, I. M., Narita, Y., Sato, H., Sztankay, M., Stockhammer, G. N., Talacchi, A., Uitdehaag, B. M. J., Reijneveld, J. C. & Taphoorn, M. J. B., 1 Aug 2022, In: Neuro-Oncology Practice. 9, 4, p. 271-283 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
Oort, Q., Zwinkels, H., Koekkoek, J. A. F., Vos, M. J., Reijneveld, J. C., Taphoorn, M. J. B. & Dirven, L., Jun 2022, In: Psycho-Oncology. 31, 6, p. 995-1002 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Is poor sleep quality associated with poor neurocognitive outcome in cancer survivors? A systematic review
Drijver, A. J., Oort, Q., Otten, R., Reijneveld, J. C. & Klein, M., 2 May 2022, (E-pub ahead of print) In: Journal of Cancer Survivorship. 18, 2, p. 207-222 16 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
